All articles by GlobalData Healthcare

  1. Brexit’s impact on UK life sciences: some key points

    Brexit. A word known by many but understood by few. Out of the various sectors that compose the UK’s economy,…
    Read More…

    13 Dec
  2. The clinical trial landscape for GSK’s latest acquisition Tesaro

    On 3 December 2018, GlaxoSmithKline (GSK) announced that it will be acquiring Tesaro to bolster its drug development portfolio, especially…
    Read More…

    11 Dec
  3. Future NASH reimbursement issues may echo HCV therapies

    Nonalcoholic steatohepatitis (NASH) therapies with prospective launches post-2020 will likely have reimbursement challenges mirroring those faced by hepatitis C (HCV)…
    Read More…

    11 Dec
  4. Next chapter of Ebola preparation begins as Merck’s V920 nears approval

    The Ebola outbreak that began in August in the Democratic Republic of Congo (DRC) has now reached over 400 cases,…
    Read More…

    11 Dec
  5. Allergan’s Phase III Botox trial for depression pushed to H2 2019

    Allergan’s Botox (onabotulinumtoxin A) Phase III trial in major depressive disorder (MDD) is slated to initiate in the second half of…
    Read More…

    10 Dec
  6. Foamix’s rosacea drug FMX103 splits views on sunburn risk

    Foamix Pharmaceuticals’ FMX103 (1.5% topical minocycline foam) has experts split over the drug’s real-world ability to protect against sunburn, despite…
    Read More…

    10 Dec
  7. ASH 2018: Celgene’s Revlimid looks set for new approvals in NHL

    Celgene has announced positive new data for its leading blockbuster drug, Revlimid (lenalidomide), which earned revenues of $8.2bn in 2017….
    Read More…

    7 Dec
  8. Can Bayer’s Jivi match up to the competition in haemophilia A market?

    On 27 November, Bayer announced EU approval of Jivi (damoctocog alfa pegol; antihemophilic factor [recombinant], PEGylated) for on-demand treatment, perioperative…
    Read More…

    5 Dec
  9. Breast cancer clinical trials: top drugs under investigation

    GlobalData analysed the number of clinical trials examining breast cancer with start dates between January 1, 2018 and November 16,…
    Read More…

    5 Dec
  10. Enrollment issues are the top factor in clinical trial terminations

    GlobalData analysed all terminated trials within the Clinical Trials Database to determine the major reasons for terminations. When “Other” and…
    Read More…

    5 Dec

Go Top